Publication | Closed Access
Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
71
Citations
0
References
1975
Year
Cancer ResearchMedicinal ChemistryOncologyMedicineImmunologySchedule DependentP388 LeukemiaPharmacotherapyTwo-drug CombinationAnti-cancer AgentCancer TreatmentCyclophosphamide-adriamycin Combination ChemotherapyPharmacologyCancer TherapeuticsCancer ChemotherapyChemotherapyTumor BiologyDrug Discovery
The two-drug combination of cyclophosphamide plus adriamycin was found to be therapeutically potentiating against four different C3H mammary tumor lines, the B16 melanoma, the Ridgway osteogenic sarcoma, and the P388 leukemia. The potentiation was not schedule dependent.